Price History

Hover for the daily close. The dotted line marks the period open.

Compare EMBC with… →

EMBC Key Statistics

As of Sep 4, 2026

Trading

Open: $5.63
Previous Close: $5.69
Day's Range: 5.60–5.91
52-Week Range: 2.77–15.55
Volume: 1.00M
Beta: 0.85

Valuation

Market Cap: $328.63M
P/E Ratio: 3.87
Forward P/E: 3.29
P/S ratio: 0.32
EPS (ttm): 1.50

Financials (FY)

Revenue (FY): $1.08B−3.80%
Net Income (FY): $95.40M+21.84%
Profit margin: 8.59%
Shares Outstanding: 56.66M
1-Year Return: −58.74%

Dividend and dates

Dividend: $0.04+0.69%
Ex-Dividend Date: August 27, 2026
Earnings Date: November 25, 2026
Avg Volume: 1.86M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

EMBC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−45.62%−23.12%+13.56%−39.64%−50.32%

2022*2023202420252026*

Year	Return
2026 (partial year)	−50.32%
2025	−39.64%
2024	+13.56%
2023	−23.12%
2022 (partial year)	−45.62%

As of September 4, 2026.

EMBC Revenue and Earnings by Fiscal Year

FY ends September

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$1.08B	$95.40M	8.8%
2024	$1.12B	$78.30M	7.0%
2023	$1.12B	$70.40M	6.3%
2022	$1.13B	$223.60M	19.8%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$1.08B	$676.80M	$296.40M	$95.40M	8.8%
2024	$1.12B	$735.20M	$285.00M	$78.30M	7.0%
2023	$1.12B	$749.90M	$224.00M	$70.40M	6.3%
2022	$1.13B	$774.90M	$368.50M	$223.60M	19.8%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

EMBC Dividend History

’22’23’24’25’26*

$0.60+0.0% vs 2024

Dividends per share, 2025 · 4 payments

Year	Dividends per share	Payments	Change
2026*	$0.17	3	—
2025	$0.60	4	+0.0%
2024	$0.60	4	+0.0%
2023	$0.60	4	+100.0%

Year	Dividends per share	Payments	Change
2026 (partial year)	$0.17	3	—
2025	$0.60	4	+0.0%
2024	$0.60	4	+0.0%
2023	$0.60	4	+100.0%
2022	$0.30	2	—

Most recent payment: $0.06 per share, ex-dividend August 27, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

EMBC Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks

Metric	EMBC	Medical Instruments & Supplies median	vs median
P/E	3.87	35.61	0.1x the median
P/S ratio	0.32	3.17	0.1x the median
Profit margin	8.59%	0.85%	7.7 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Embecta Corp. (EMBC) at $328.63M. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 1,850.

EMBC last closed at $5.80 on September 4, 2026. That is +$0.11 (+1.93%) against the previous close. The 52-week range on file runs from $2.77 to $15.55. The latest close sits 109.39% above that 52-week low.

Financial Health

In fiscal 2025, Embecta Corp. reported revenue of $1.08B. That is −3.80% against the prior fiscal year, when revenue was $1.12B. The same year closed with net income of $95.40M. That is +21.84% against the prior fiscal year. The reported profit margin is 8.59%. That is 7.7 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 1.5.

Across the 4 fiscal years on file, revenue moves from $1.13B in 2022 to $1.08B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 3.87. That is 0.1 times the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 3.29. The price-to-sales ratio is 0.32. On price-to-sales that is 0.1 times the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

Beta against the wider market is reported at 0.85. Daily returns over the trailing 4 years annualize to a volatility of 64.45%. The trailing one-year price return is −58.74%. Measured over 3 years, that is −29.11% a year compounded.

Growth & Income

Shareholders receive a dividend, yielding 0.69% on the latest price. That is 0.3 percentage points below the Medical Instruments & Supplies median yield of 0.97%. The indicated annual rate is $0.04 a share. The ex-dividend date on file is August 27, 2026. Dividends are recorded for 5 calendar years; 2026 shows 3 payments totalling $0.17 a share. The year before, 2025, totalled $0.60 a share.

So far in 2026 the price is −50.32%. The strongest complete calendar year on file is 2024 at +13.56%; the weakest is 2025 at −39.64%. Of the 3 complete calendar years on file, 1 finished higher.

Peer Comparison

Embecta Corp. (EMBC) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Embecta Corp.	EMBC	$328.63M	3.9
Intuitive Surgical, Inc.	ISRG	$131.38B	42.4
Becton, Dickinson and Company	BDX	$50.32B	32.0
Medline Inc.	MDLN	$49.23B	45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Embecta Corp. trades at a P/E of 3.9.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

BDX

Becton, Dickinson and Company

$50.32B

MDLN

Medline Inc.

$49.23B

ALC

Alcon Inc.

$34.08B

RMD

ResMed Inc.

$32.94B

WST

West Pharmaceutical Services, Inc.

$23.93B

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Embecta Corp.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Visit website →

Embecta Corp. (EMBC) Stock Analysis